JENNIFER POOL: Open Payments
NPI 1407457211 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 18 payments from 10 companies in 2025. Trend: 2023 $645 · 2024 $548 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $151 |
| ABBVIE INC. | 3 | $53 |
| Amgen Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: Wegovy, VRAYLAR, REPATHA, VOQUEZNA, JARDIANCE, BREZTRI, TRELEGY ELLIPTA, NEXLETOL.
Industry payments across NE — which companies pay providers there.
